Clinicians often reserve vigilance with drug-related issues for critically ill patients or older populations, while mistaking the resilience of childhood as a protective barrier.
Katherine E. MacDonald
Advertisement
Articles by Katherine E. MacDonald
Advertisement
Latest Updated Articles
Be Vigilant With Pediatric PopulationsPublished: September 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
4
Hyperlipidemia Causally Linked to Increased Risk of Alzheimer Disease
5
